Vita 34 AG
XETRA:V3V
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
DE |
Vita 34 AG
XETRA:V3V
|
74.4m EUR | 21.3 | ||
US |
Cigna Corp
NYSE:CI
|
98.7B USD | 10.4 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
91.3B EUR | 10.4 | |
US |
CVS Health Corp
NYSE:CVS
|
68.7B USD | 10.7 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16B EUR | 6.2 | |
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 17 | ||
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.1B USD | 13.8 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.3B EUR | 7.9 | |
US |
DaVita Inc
NYSE:DVA
|
11.9B USD | 14.1 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11B EUR | 7.7 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -32.4 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.